Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.
Torres A, Wible M, Tawadrous M, Irani P, Stone GG, Quintana A, Debabov D, Burroughs M, Bradford PA, Kollef M. Torres A, et al. Among authors: debabov d. J Antimicrob Chemother. 2023 Nov 6;78(11):2672-2682. doi: 10.1093/jac/dkad280. J Antimicrob Chemother. 2023. PMID: 37700689 Clinical Trial.
Real-world in vitro activity of newer antibiotics against Enterobacterales and Pseudomonas aeruginosa, including carbapenem-non-susceptible and multidrug-resistant isolates: a multicenter analysis.
Riccobene T, Ai C, Yu KC, Gregory S, Kim B, Debabov D, Gupta V. Riccobene T, et al. Among authors: debabov d. Microbiol Spectr. 2023 Dec 12;11(6):e0312923. doi: 10.1128/spectrum.03129-23. Epub 2023 Nov 8. Microbiol Spectr. 2023. PMID: 37937985 Free PMC article.
Antimicrobial Activity of Ceftazidime-Avibactam and Comparators against Pathogens Harboring OXA-48 and AmpC Alone or in Combination with Other β-Lactamases Collected from Phase 3 Clinical Trials and an International Surveillance Program.
Lin LY, Debabov D, Chang W, Stone G, Riccobene T. Lin LY, et al. Among authors: debabov d. Antimicrob Agents Chemother. 2022 Mar 15;66(3):e0198521. doi: 10.1128/AAC.01985-21. Epub 2022 Mar 15. Antimicrob Agents Chemother. 2022. PMID: 35225651 Free PMC article.
Approved Glycopeptide Antibacterial Drugs: Mechanism of Action and Resistance.
Zeng D, Debabov D, Hartsell TL, Cano RJ, Adams S, Schuyler JA, McMillan R, Pace JL. Zeng D, et al. Among authors: debabov d. Cold Spring Harb Perspect Med. 2016 Dec 1;6(12):a026989. doi: 10.1101/cshperspect.a026989. Cold Spring Harb Perspect Med. 2016. PMID: 27663982 Free PMC article. Review.
36 results